LONDON (Alliance News) - PureTech Health PLC on Monday said that its affiliate, Karuna Therapeutics Inc, has filed a public registration statement with the US Securities & Exchange Commission to list on Nasdaq.
The number of shares to be offered and the price range for the offering have not yet been determined, PureTech, the founder of clinical-stage biopharmaceutical firm Karuna, added.
Goldman Sachs & Co LLC and Citigroup are acting as joint book-running managers for the proposed offering. Wells Fargo Securities is serving as a joint book-running manager and Wedbush PacGrow is acting as co-manager.
PureTech Health shares were trading 4.8% higher at 217.90 pence each on Monday afternoon.
PureTech (PRTC)